[Modalities of mobilization and hematopoietic stem cells objectives in autologous transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

Bull Cancer. 2020 Jan;107(1S):S44-S51. doi: 10.1016/j.bulcan.2019.08.007. Epub 2019 Sep 27.
[Article in French]

Abstract

The modalities of mobilization of hematopoietic stem cells in autologous transplantation have evolved in recent years. The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organized the 9th hematopoietic stem cell transplantation clinical practices harmonization workshop series in September 2018 in Lille, France, to conduct a review of current practices of the society centers and of international recommendations. The cell dose objectives have been revised. The modalities of mobilization including the use of plerixafor have been specified allowing reaching the objectives of collection while limiting the number of apheresis. Collections failures have become exceptional.

Keywords: Autogreffe de cellules souches; Autologous stem cell transplantation; Cellules souches hématopoïétiques; Hematopoietic stem cells; Mobilisation; Mobilization; Plerixafor.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Algorithms
  • Antigens, CD34 / analysis
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Benzylamines
  • Blood Component Removal / methods
  • Bone Marrow / drug effects
  • Cell Count
  • Cell Separation / methods
  • Cyclams
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Hematopoietic Cell Growth Factors / pharmacology
  • Hematopoietic Stem Cell Mobilization / methods*
  • Hematopoietic Stem Cell Mobilization / standards
  • Hematopoietic Stem Cell Transplantation*
  • Heterocyclic Compounds / pharmacology
  • Humans
  • Practice Patterns, Physicians'
  • Risk Factors
  • Transplantation, Autologous

Substances

  • Antigens, CD34
  • Antineoplastic Agents
  • Benzylamines
  • Cyclams
  • Hematopoietic Cell Growth Factors
  • Heterocyclic Compounds
  • Granulocyte Colony-Stimulating Factor
  • plerixafor